Evidence map›Paper›PMID 29737502›Full record

ReviewDrug safety2018

Vitamin B

Florence van Hunsel, Sonja van de Koppel, Eugène van Puijenbroek, Agnes Kant

Open access · greenAbstract readCase ReportsReview
PubMed Publisher
In one paragraph

Review in Drug safety, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Scientific opinion on the tolerable upper intake level for vitamin B6.EFSA journal. European Food Safety Authority · 2023
    Article
  12. Article
  13. Review
  14. Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Florence van HunselNetherlands Pharmacovigilance Centre Lareb, 5237 MH, 's-Hertogenbosch, The Netherlands. f.vanhunsel@lareb.nl.ORCID http://orcid.org/0000-0001-8965-3224
Sonja van de KoppelNetherlands Pharmacovigilance Centre Lareb, 5237 MH, 's-Hertogenbosch, The Netherlands.
Eugène van PuijenbroekNetherlands Pharmacovigilance Centre Lareb, 5237 MH, 's-Hertogenbosch, The Netherlands.ORCID http://orcid.org/0000-0002-2236-1398
Agnes KantNetherlands Pharmacovigilance Centre Lareb, 5237 MH, 's-Hertogenbosch, The Netherlands.
Netherlands Pharmacovigilance Centre Lareb · NLUniversity of Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn the literature, vitamin B

objectiveWe aim to comprehensively describe the cases of neuropathy associated with vitamin B

methodsWe describe the number and nature of the reported cases, including suspect product, dosage, duration of use, and vitamin B

resultsIn total, 90 reports on products containing vitamin B DISCUSSION AND

conclusionCausality assessment of the case series of 90 reports to Lareb shows it is plausible for the vitamin B

Indexed as

AdultAdverse Drug Reaction Reporting SystemsDietary SupplementsFemaleHumansMaleMiddle AgedPeripheral Nervous System DiseasesVitamin B 6Vitamin B 6

Identifiers

PMID29737502
OpenAlexW2802831923

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.